Literature DB >> 9735340

Molecular identification of a role for tyrosine 167 in the function of the human intestinal proton- coupled dipeptide transporter (hPepT1).

A K Yeung1, S K Basu, S K Wu, C Chu, C T Okamoto, S F Hamm-Alvarez, H von Grafenstein, W C Shen, K J Kim, M B Bolger, I S Haworth, D K Ann, V H Lee.   

Abstract

hPepT1 is a proton-coupled peptide transporter that mediates the absorption of di- and tripeptides. Here we show that tyrosine 167 (Y167) in transmembrane domain 5 (TMD5) of this 12-transmembrane spanning protein contributes to its transport function. We identified this particular amino acid by a computer model of the arrangement of the TMDs of hPepT1 and investigated its role by site-directed mutagenesis and dipeptide uptake studies. [3H]Gly-sar uptake in cells transiently transfected with Y167A-hPepT1 was abolished completely, even though the level of Y167A-hPepT1 expression by Western blot analysis and cell surface expression by immunofluorescence microscopy was similar to those of the wild type. Therefore, mutation affected transport function, but apparently not the steady-state protein level or trafficking of the transporter to the plasma membrane. Moreover, mutation of Y167 into phenylalanine, serine, or histidine all abolished gly-sar uptake in transfected HEK 293 cells. Taken together, these findings suggest that Y167 plays an essential role in hPepT1 function, perhaps due to the unique chemistry of its phenolic side chain. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9735340     DOI: 10.1006/bbrc.1998.9283

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  20 in total

Review 1.  Intestinal peptide transport systems and oral drug availability.

Authors:  C Y Yang; A H Dantzig; C Pidgeon
Journal:  Pharm Res       Date:  1999-09       Impact factor: 4.200

2.  N-terminal halves of rat H+/peptide transporters are responsible for their substrate recognition.

Authors:  T Terada; H Saito; K Sawada; Y Hashimoto; K Inui
Journal:  Pharm Res       Date:  2000-01       Impact factor: 4.200

Review 3.  Bioavailability through PepT1: the role of computer modelling in intelligent drug design.

Authors:  David W Foley; Jeyaganesh Rajamanickam; Patrick D Bailey; David Meredith
Journal:  Curr Comput Aided Drug Des       Date:  2010-03       Impact factor: 1.606

4.  Functional and structural determinants of reverse operation in the pH-dependent oligopeptide transporter PepT1.

Authors:  Maria Daniela Renna; Ayodele Stephen Oyadeyi; Elena Bossi; Gabor Kottra; Antonio Peres
Journal:  Cell Mol Life Sci       Date:  2010-12-23       Impact factor: 9.261

5.  Stable transfection of MDCK cells with epitope-tagged human PepT1.

Authors:  Chun Chu; Curtis T Okamoto; Sarah F Hamm-Alvarez; Vincent H L Lee
Journal:  Pharm Res       Date:  2004-11       Impact factor: 4.200

6.  Biophysical evidence for His57 as a proton-binding site in the mammalian intestinal transporter hPepT1.

Authors:  Tomomi Uchiyama; Ashutosh A Kulkarni; Daryl L Davies; Vincent H L Lee
Journal:  Pharm Res       Date:  2003-12       Impact factor: 4.200

Review 7.  Proton-coupled oligopeptide transporter family SLC15: physiological, pharmacological and pathological implications.

Authors:  David E Smith; Benjamin Clémençon; Matthias A Hediger
Journal:  Mol Aspects Med       Date:  2013 Apr-Jun

8.  Mutagenesis and cysteine scanning of transmembrane domain 10 of the human dipeptide transporter.

Authors:  Liya Xu; Ian S Haworth; Ashutosh A Kulkarni; Michael B Bolger; Daryl L Davies
Journal:  Pharm Res       Date:  2009-08-14       Impact factor: 4.200

9.  Peptide transporter DtpA has two alternate conformations, one of which is promoted by inhibitor binding.

Authors:  Christian A Bippes; Lin Ge; Marcel Meury; Daniel Harder; Zöhre Ucurum; Hannelore Daniel; Dimitrios Fotiadis; Daniel J Müller
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-30       Impact factor: 11.205

Review 10.  Molecular modeling of PepT1--towards a structure.

Authors:  D Meredith; R A Price
Journal:  J Membr Biol       Date:  2007-04-06       Impact factor: 1.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.